Big Moving Stocks for Aug-10 At The Close

These stocks are posting some big moves for today.

Aquinox Pharmaceuticals Inc  (AQXP) < (AQXP) is currently trading at $24.10 + 13.68 (131.29%) on 15,448,286 shares traded. Aquinox Pharmaceuticals Inc  (AQXP) < is +221.33% year-to-date, and +155.14% over the last 12 months.

Aquinox Pharmaceuticals Inc is a clinical-stage pharmaceutical company. The Company along with its wholly owned subsidiary is engaged in discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology.

Zynerba Pharmaceuticals Inc (ZYNE) < (ZYNE) is currently trading at $41.00 + 16.46 (67.07%) on 439,288 shares traded. Zynerba Pharmaceuticals Inc (ZYNE) < is -- year-to-date, and -- over the last 12 months.

Zynerba Pharmeceuticals Incu00A0is a specialty pharmaceutical company focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery.

Voltari Corporation (VLTC) < (VLTC) is currently trading at $9.77 + 2.36 (31.85%) on 15,016,246 shares traded. Voltari Corporation (VLTC) < is +1,380.30% year-to-date, and +385.87% over the last 12 months.

Voltari Corp provides integrated mobile content solutions for handheld and mobile devices in the USA, Canada, and France.

Inovio Pharmaceuticals Inc. (INO) < (INO) is currently trading at $8.18 + 1.69 (26.04%) on 15,278,286 shares traded. Inovio Pharmaceuticals Inc. (INO) < is -10.89% year-to-date, and -17.77% over the last 12 months.

Inovio Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The Company develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases.

Hudson Global Inc. (HSON) < (HSON) is currently trading at $2.51 + 0.39 (18.40%) on 101,755 shares traded. Hudson Global Inc. (HSON) < is -18.90% year-to-date, and -28.81% over the last 12 months.

Hudson Global Inc., provides permanent recruitment, contract consulting, legal eDiscovery, recruitment process outsourcing and talent management solutions and also provides other recruitment and talent-related solutions.

Century Aluminum Company (CENX) < (CENX) is currently trading at $6.04 + 0.855 (16.51%) on 5,196,922 shares traded. Century Aluminum Company (CENX) < is -75.27% year-to-date, and -69.41% over the last 12 months.

Century Aluminum Co produces primary aluminum. The Company’su00A0primary aluminumis an internationally traded commodity. Its primary aluminum facilities produces value-added and standard-grade primary aluminum products.

Esperion Therapeutics Inc. (ESPR) < (ESPR) is currently trading at $67.76 + 9.02 (15.36%) on 1,470,694 shares traded. Esperion Therapeutics Inc. (ESPR) < is +67.56% year-to-date, and +345.37% over the last 12 months.

Esperion Therapeutics Inc is engaged in the research, development and commercialization of therapies for the treatment of patients with elevated levels of elevated levels of LDL-C.

OncoSec Medical Inc (ONCS) < (ONCS) is currently trading at $5.65 + 0.74 (15.07%) on 190,401 shares traded. OncoSec Medical Inc (ONCS) < is -39.89% year-to-date, and -34.94% over the last 12 months.

OncoSec Medical Inc is a hybrid device and gene therapy biotechnology company. It is engaged in designing, developing and commercializing medical approaches for treatment of cancer.

Immune Design Corp (IMDZ) < (IMDZ) is currently trading at $21.89 + 2.85 (14.97%) on 72,819 shares traded. Immune Design Corp (IMDZ) < is -28.88% year-to-date, and +83.91% over the last 12 months.

Immune Design Corp is a clinical stage immuno-therapy company with next-generation in vivo approaches designed to enable the body’s immune system to fight disease.

BioCryst Pharmaceuticals Inc. (BCRX) < (BCRX) is currently trading at $12.30 + 1.40 (12.84%) on 1,922,398 shares traded. BioCryst Pharmaceuticals Inc. (BCRX) < is +1.15% year-to-date, and -12.18% over the last 12 months.

Biocryst Pharmaceuticals Inc is au00A0biotechnology company. The Companyu00A0designs, optimizes and develops novel small molecule drugs that block key enzymes involved in the pathogenesis of diseases.

Alex Fredricks

Alex Fredricks

Alex Fredricks has a degree in business and is an avid day-trader. Alex's experience and love for the game of the markets is shown not only in his posts, but the post he helps edit for other authors on our staff.